Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

GIUSEPPE BADALAMENTI

Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation

  • Authors: VALERIO MR; CICERO G; SCIBILIA C; ADILE C; CROSTA A; ARCARA C; BADALAMENTI G; VIZZINI L; SPINNATO F; INTRIVICI C; FULFARO F
  • Publication year: 2006
  • Type: eedings
  • OA Link: http://hdl.handle.net/10447/12590